Does Arterial Calcification Increase Mortality?

TL;DR: Arterial calcification is a well-established predictor of cardiovascular mortality. Higher coronary artery calcium scores are consistently associated with greater risk of heart attack, stroke, and cardiovascular death — though the risk depends on the extent and location of calcification, and lifestyle and medical management can slow its progression.

What Is Arterial Calcification?

Arterial calcification is the accumulation of calcium deposits within arterial walls, causing them to stiffen and lose elasticity. It is a well-recognised feature of vascular aging and advanced atherosclerosis. While some degree of arterial stiffening occurs with normal aging, significant calcification — particularly in the coronary arteries — is not simply a benign age-related change. It is a clinically meaningful finding with established links to cardiovascular risk.

Calcification can occur in two main forms: intimal calcification, which develops within atherosclerotic plaques, and medial calcification (also called Mönckeberg sclerosis), which affects the muscular layer of the arterial wall. Both forms reduce vascular compliance, but intimal calcification carries a stronger association with atherosclerotic disease and cardiovascular events. Understanding this distinction matters, because not all calcification carries identical risk.

Coronary artery calcium (CAC) scoring — measured via CT scan — is the most widely used clinical tool for quantifying calcification in the coronary arteries. It is a validated, non-invasive measure used in cardiovascular risk assessment, and it forms a central part of how clinicians interpret calcification in the context of mortality risk. For broader context on how arteries age and why calcification develops, see our article on how arterial calcification develops.

Does Arterial Calcification Increase Mortality Risk?

Yes — the evidence is consistent and substantial. Higher coronary artery calcium scores are associated with significantly increased risk of cardiovascular mortality and all-cause mortality across multiple large prospective studies. This relationship holds even after adjusting for traditional cardiovascular risk factors such as age, blood pressure, cholesterol, and smoking.

The Multi-Ethnic Study of Atherosclerosis (MESA), one of the largest studies in this area, demonstrated that individuals with higher CAC scores faced substantially greater cardiovascular event rates compared to those with a CAC score of zero. Importantly, a CAC score of zero is associated with very low short-term cardiovascular risk, even in people with other risk factors — a finding that has influenced clinical guidelines around statin prescribing and preventive treatment decisions.

That said, it is important to distinguish between arterial calcification as a risk marker and as a direct cause of death. Calcification indicates the presence and severity of underlying atherosclerosis. It is the atherosclerotic process — plaque rupture, thrombosis, arterial obstruction — that most directly drives cardiovascular events. However, calcification itself also contributes mechanically, by reducing arterial flexibility, raising pulse pressure, and increasing the haemodynamic stress on the heart and vessel walls. As a result, it is both a marker and an active contributor to elevated risk.

This article is part of our organ-specific aging hub, which covers how different organ systems decline with age and what the evidence says about slowing that decline.

How Calcification Contributes to Cardiovascular Events

Arterial calcification increases mortality risk through several interconnected mechanisms.

Reduced arterial elasticity. Calcified arteries cannot expand and contract efficiently with each heartbeat. This raises systolic blood pressure and widens pulse pressure — both of which place increased mechanical strain on the heart and are independent predictors of cardiovascular risk. Over time, this can contribute to left ventricular hypertrophy and heart failure.

Atherosclerotic plaque burden. Intimal calcification develops within atherosclerotic plaques and reflects cumulative arterial injury and inflammation. The greater the calcification, in general, the more extensive the underlying disease. Importantly, plaque rupture — not calcification itself — is the immediate trigger for most heart attacks and strokes. However, heavily calcified plaques may be associated with more complex coronary anatomy, making intervention more technically challenging if an event occurs.

Impaired endothelial function. Chronic inflammation and oxidative stress — the same processes that drive atherosclerosis — also impair endothelial function, reducing the ability of arteries to regulate blood flow. This further elevates cardiovascular risk in individuals with significant calcification.

It is worth noting that some research has suggested calcified plaques may be more structurally stable than non-calcified, lipid-rich plaques — meaning they are potentially less prone to acute rupture. However, this does not reduce overall risk in individuals with high calcium scores, as the total burden of disease reflected by calcification is itself the dominant concern. Learn more in our complete guide to longevity.

Preventive Measures and Management Strategies

Arterial calcification, once established, is generally not reversible. Existing calcium deposits within arterial walls do not dissolve with lifestyle change or medication. However, the progression of calcification can be slowed, and — more importantly — the cardiovascular risk associated with it can be meaningfully reduced through targeted management.

Lifestyle factors. The same interventions that reduce overall cardiovascular risk are relevant here. Regular aerobic exercise improves endothelial function, lowers blood pressure, and supports healthy lipid profiles. A diet low in refined carbohydrates and trans fats, and rich in vegetables, whole grains, and omega-3 fatty acids, reduces systemic inflammation and atherosclerotic burden. Avoiding tobacco is critical — smoking significantly accelerates vascular aging and arterial calcification. Managing chronic psychological stress also appears to have a modest but real cardiovascular benefit.

Medical management. Statins are the most evidence-backed pharmacological intervention for reducing cardiovascular mortality in people with established calcification or high CAC scores. Importantly, statins may actually increase the density of existing plaques (a process sometimes visible on imaging), but this does not reflect worsening disease — the overall cardiovascular outcome with statins is clearly improved in high-risk individuals. Blood pressure control is equally important, as hypertension accelerates arterial wall damage and calcification progression.

Risk stratification. CAC scoring is particularly useful for reclassifying risk in intermediate-risk individuals — those for whom the decision to start statins or other preventive therapy is uncertain based on traditional risk calculators alone. A high CAC score in this group generally supports more aggressive preventive intervention. A score of zero may justify a more conservative approach and watchful monitoring. These decisions should always be made in partnership with a clinician who can contextualise results within an individual’s full risk profile.

For a broader view of how aging affects arterial health and other organ systems, the article on arterial calcification and mortality provides additional clinical context alongside our organ-specific aging overview.

References and Resources

Authoritative Sources on Arterial Calcification and Mortality

Frequently Asked Questions

Does arterial calcification directly cause higher mortality, or is it just a marker?

Both. Arterial calcification is a reliable marker of underlying atherosclerosis, which independently drives mortality risk. However, calcification also contributes mechanically — reducing arterial elasticity, raising blood pressure, and increasing cardiac strain. As a result, it is best understood as both a predictor and an active contributor to elevated cardiovascular risk, rather than simply a passive indicator.

Can lifestyle changes reduce arterial calcification and lower mortality risk?

Lifestyle changes are unlikely to reverse existing calcification, but they can slow progression and substantially reduce the cardiovascular risk associated with it. Regular exercise, a heart-healthy diet, smoking cessation, and blood pressure control are all supported by evidence. These interventions target the underlying atherosclerotic process and overall cardiovascular health, which is where meaningful risk reduction occurs.

Is arterial calcification reversible?

In practical terms, no. Established calcium deposits within arterial walls do not dissolve with currently available treatments. Some imaging studies have shown increased calcium density with statin therapy, but this reflects plaque stabilisation rather than reversal — and cardiovascular outcomes with statins are clearly improved. Early detection and risk factor management remain the most effective strategies for limiting long-term harm.

What are the best ways to prevent arterial calcification from increasing mortality risk?

The most evidence-supported approach combines lifestyle and medical management: controlling blood pressure and cholesterol, maintaining a healthy weight, avoiding tobacco, and engaging in regular aerobic exercise. For individuals with high coronary artery calcium scores, statins and other preventive medications are generally recommended based on clinical guidelines. Risk stratification using CAC scoring can help guide treatment decisions, particularly in people with intermediate cardiovascular risk.

Conclusion

Arterial calcification is a well-established predictor of cardiovascular mortality, supported by consistent evidence across large prospective studies. Higher coronary artery calcium scores reflect greater atherosclerotic burden and are associated with meaningfully elevated risks of heart attack, stroke, and cardiovascular death. While calcification itself is not reversible, its progression can be slowed and the associated mortality risk can be substantially reduced through targeted lifestyle changes and, where appropriate, medical management. Proactive risk stratification — rather than alarm about normal vascular aging — is the most clinically useful response to this finding.

Similar Posts